Twitter prank spurs unexpected scrutiny of insulin prices
INSUBCONTINENT EXCLUSIVE:
WASHINGTON: A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis
-- a new wave of scrutiny of the high cost of its insulin.
